Clinical performance of FractionLab in patient-specific quality assurance for intensity-modulated radiotherapy: a retrospective study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: This study was aimed at comparing and analyzing the results of FractionLab (Varian/Mobius Medical System) with those of portal dosimetry that uses an electronic portal imaging device. Portal dosimetry is extensively used for patient-specific quality assurance (QA) in intensity-modulated radiotherapy (IMRT). Methods: The study includes 29 patients who underwent IMRT on a Novalis-Tx linear accelerator (Varian Medical System and BrainLAB) between June 2019 and March 2021. We analyzed the multileaf collimator (MLC) DynaLog files generated after portal dosimetry to evaluate the same condition using FractionLab. The results of the recently launched FractionLab at various gamma indices (0.1%/0.1 mm–1%/1 mm) are analyzed and compared with those of portal dosimetry (3%/3 mm). Results: The average gamma passing rates of portal dosimetry (3%/3 mm) and FractionLab are 98.1 (95.5%–100%) and 97.5% (92.3%–99.7%) at 0.6%/0.6 mm, respectively. The results of portal dosimetry (3%/3 mm) are statistically comparable with the QA results of FractionLab (0.6%/0.6 mm–0.9%/0.9 mm).Conclusion: This paper presents the clinical performance of FractionLab by the comparison of the QA results of FractionLab using portal dosimetry with various gamma indexes when performing patient-specific QA in IMRT treatment. Further, the appropriate gamma index when performing patient-specific QA with FractionLab is provided.
Abstract
Background: This study was aimed at comparing and analyzing the results of FractionLab (Varian/Mobius Medical System) with those of portal dosimetry that uses an electronic portal imaging device. Portal dosimetry is extensively used for patient-specific quality assurance (QA) in intensity-modulated radiotherapy (IMRT). Methods: The study includes 29 patients who underwent IMRT on a Novalis-Tx linear accelerator (Varian Medical System and BrainLAB) between June 2019 and March 2021. We analyzed the multileaf collimator (MLC) DynaLog files generated after portal dosimetry to evaluate the same condition using FractionLab. The results of the recently launched FractionLab at various gamma indices (0.1%/0.1 mm–1%/1 mm) are analyzed and compared with those of portal dosimetry (3%/3 mm). Results: The average gamma passing rates of portal dosimetry (3%/3 mm) and FractionLab are 98.1 (95.5%–100%) and 97.5% (92.3%–99.7%) at 0.6%/0.6 mm, respectively. The results of portal dosimetry (3%/3 mm) are statistically comparable with the QA results of FractionLab (0.6%/0.6 mm–0.9%/0.9 mm).Conclusion: This paper presents the clinical performance of FractionLab by the comparison of the QA results of FractionLab using portal dosimetry with various gamma indexes when performing patient-specific QA in IMRT treatment. Further, the appropriate gamma index when performing patient-specific QA with FractionLab is provided.
참고문헌 (21)
- Dai X, "Volumetric-modulated arc therapy for oropharyngeal carcinoma : a dosimetric and delivery efficiency comparison with static-field IMRT", Phys Med, 31, pp.54~59 (2015)
- Ali M, "Comparative dosimetric analysis of IMRT and VMAT(RapidArc)in brain, head and neck, breast and prostate malignancies", Int J Cancer Ther Oncol, 3, pp.03019~ (2015)
- Karthick Raj Mani, "Influence of jaw tracking in intensity-modulated and volumetric-modulated arc radiotherapy for head and neck cancers: a dosimetric study", Radiation oncology journal, 35(1), pp.90~100 (2017), 대한방사선종양학회
- Liu X, "Dosimetric comparison of helical tomotherapy, VMAT, fixed-field IMRT and 3D-conformal radiotherapy for stage I-II nasal natural killer T-cell lymphoma", Radiat Oncol, 12, pp.76~ (2017)
- Deng X, "Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients", J Appl Clin Med Phys, 18, pp.25~31 (2017)
- Mellon EA, "A dosimetric comparison of volumetric modulated arc therapy with step-and-shoot intensity modulated radiation therapy for prostate cancer", Pract Radiat Oncol, 5, pp.11~15 (2015)
- Oh SA, "Use of a head-tilting baseplate during volumetric-modulated arc therapy(VMAT)to better protect organs at risk in hippocampal sparing whole brain radiotherapy(HS-WBRT)", PLoS One, 15, pp.e0232430~ (2020)
- 오세안, "Comparison of IMRT and VMAT Techniques in Spine Stereotactic Radiosurgery with International Spine Radiosurgery Consortium Consensus Guidelines", 의학물리, 24(3), pp.145~153 (2013), 한국의학물리학회[DOI]
- 허승재, "Recent trends in intensity-modulated radiation therapy use in Korea", Radiation oncology journal, 37(4), pp.249~253 (2019), 대한방사선종양학회
- 김정인, "Gamma Evaluation with Portal Dosimetry for Volumetric Modulated Arc Therapy and Intensity-Modulated Radiation Therapy", 의학물리, 28(2), pp.61~66 (2017), 한국의학물리학회[DOI]
- Yea JW, "Feasibility of a 3D-printed anthropomorphic patient-specific head phantom for patient-specific quality assurance of intensity-modulated radiotherapy", PLoS One, 12, pp.e0181560~ (2017)
- Ezzell GA, "IMRT commissioning : multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119", Med Phys, 36, pp.5359~5373 (2009)
- 오세안, "Dosimetric Verifications of the Output Factors in the Small Field Less Than 3 cm2 Using the Gafchromic EBT2 Films and the Various Detectors", 의학물리, 25(4), pp.218~224 (2014), 한국의학물리학회[DOI]
- 오세안, "Comparison of Intensity Modulated Radiation Therapy Dose Calculations with a PBC and AAA Algorithms in the Lung Cancer", 의학물리, 23(1), pp.48~53 (2012), 한국의학물리학회[DOI]
- Olaciregui-Ruiz I, "Transit and non-transit 3D EPID dosimetry versus detector arrays for patient specific QA", J Appl Clin Med Phys, 20, pp.79~90 (2019)
- Han B, "Pixel response-based EPID dosimetry for patient specific QA", J Appl Clin Med Phys, 18, pp.9~17 (2017)
- Defoor DL, "Investigation of error detection capabilities of phantom, EPID and MLC log file based IMRT QA methods", J Appl Clin Med Phys, 18, pp.172~179 (2017)
- "DoseLab user guide - version 7.0" (2018)[URL]
- 김연래, "Comparison of the Performance between Portal Dosimetry and a Commercial Two-dimensional Array System on Pretreatment Quality Assurance for Volumetric-modulated Arc and Intensity-modulated Radiation Therapy", Journal of the Korean Physical Society, 64(8), pp.1202~1206 (2014), 한국물리학회
- Krishna Murthy K, "Patient-specific quality assurance of RapidArc treatments : portal prediction dosimetry compared with phantom studies", Biomed Imaging Interv J, 8, pp.e28~ (2012)
- Stanhope CW, "Evaluation of machine log files", MC-based treatment planning and delivery QA as compared to ArcCHECK QA, 2018, pp.45, 2864~2874